Market Place
Sourcing Support
Orchestra BioMed to Attend Jefferies London Healthcare Conference
07 Nov 2024 //
GLOBENEWSWIRE
Orchestra BioMed Reports Q2 2024 Results And Provides Business Update
12 Aug 2024 //
GLOBENEWSWIRE
Orchestra BioMed: R&D Day Details On AVIM Therapy For Hypertensive Pacemakers
04 Jun 2024 //
GLOBENEWSWIRE
Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
22 May 2024 //
GLOBENEWSWIRE
Orchestra BioMed Q1 2024 Financials, Business Update
13 May 2024 //
GLOBENEWSWIRE
Orchestra BioMed To Host R&D Day On AVIM In Hypertensive Pacemakers
30 Apr 2024 //
GLOBENEWSWIRE
Orchestra BioMed`s AVIM Therapy IP Reaches 110 Issued Patents
30 Apr 2024 //
GLOBENEWSWIRE
Orchestra BioMed Reports Full Year 2023 Financial Results
27 Mar 2024 //
GLOBENEWSWIRE
Orchestra Announces Appointment of David to Board of Directors
26 Mar 2024 //
GLOBENEWSWIRE
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy
08 Jan 2024 //
GLOBENEWSWIRE
Orchestra BioMed to Present at Upcoming Investor Conferences
09 Nov 2023 //
GLOBENEWSWIRE
Orchestra Granted FDA Approval of IDE to Initiate BACKBEAT Study of BackBeat
19 Sep 2023 //
GLOBENEWSWIRE
Orchestra BioMed Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Orchestra Granted Approval for Study of Virtue Sirolimus AngioInfusion Balloon
08 Aug 2023 //
GLOBENEWSWIRE
Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes
26 Jun 2023 //
GLOBENEWSWIRE
Orchestra BioMed Appoints Bill Little as Executive Vice President
07 Jun 2023 //
GLOBENEWSWIRE
Orchestra BioMed to Present at the Jefferies Global Healthcare Conference
01 Jun 2023 //
GLOBENEWSWIRE
Orchestra BioMed Reports First Quarter 2023 Financial Results
12 May 2023 //
GLOBENEWSWIRE
Orchestra BioMed to Present at Upcoming Investor Conferences
07 Mar 2023 //
GLOBENEWSWIRE
Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT SAB at CRT
24 Feb 2023 //
GLOBENEWSWIRE
Orchestra BioMed Strengthens Senior Leadership Team
07 Feb 2023 //
GLOBENEWSWIRE
Orchestra Debuts as Nasdaq-Traded Company with Programs Targeting Hypertension
27 Jan 2023 //
GLOBENEWSWIRE
Orchestra BioMed™ Announces Presentation of Positive Clinical Results
20 Sep 2022 //
GLOBENEWSWIRE
Orchestra BioMed implant cuts hypertension in extended study
20 Sep 2022 //
FIERCEBIOTECH
Orchestra BioMed cues up Medtronic collab, $400M SPAC deal
05 Jul 2022 //
FIERCEBIOTECH
Orchestra BioMed Announces Strategic Collaboration, Closing of $110M PEF
05 Jul 2022 //
GLOBENEWSWIRE
Orchestra to Present Positive Long-Term Clinical Results at TCT 2021
05 Nov 2021 //
GLOBENEWSWIRE
Orchestra Announces Peer-Reviewed Publication of MODERATO II Study Results
17 Aug 2021 //
GLOBENEWSWIRE
